| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 07/22/2004 | US20040142431 Nucleotide sequences comprising restriction fragment length polymorphisms coding polypeptide with antiproliferative, antiviral and antiparasitic effects |
| 07/22/2004 | US20040142391 Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with RAGE |
| 07/22/2004 | US20040142001 contains Radix, Cortex, Medulla, Rhizoma, Caulis, Herba, Semen, Rhizoma, Olibanum, Fructus, Myrrha, Gypsum, Folium, Herba, Polyporus, Stigma, Phaseolus and other natural components; preferably further comprises Ganoderma Lucidum. |
| 07/22/2004 | US20040141966 Inhibition of leukocyte adhesion |
| 07/22/2004 | US20040141949 Treatment of mucositis |
| 07/22/2004 | DE202004003404U1 Pharmazeutische Zusammensetzung zur kontrollierten Freisetzung von Wirkstoffen A pharmaceutical composition for controlled release of active ingredients |
| 07/21/2004 | EP1439175A1 Pyrimidine compound and medicinal composition thereof |
| 07/21/2004 | EP1439174A1 4-imidazolin-2-one compounds |
| 07/21/2004 | EP1438583A2 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 07/21/2004 | EP1438316A1 Phosphonic acid compounds as inhibitors of serine proteases |
| 07/21/2004 | EP1438313A1 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 07/21/2004 | EP1438309A1 Quinuclidine derivatives, processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors |
| 07/21/2004 | EP1438307A2 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist |
| 07/21/2004 | EP1438304A1 Novel substituted 4-phenyl-4- 1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
| 07/21/2004 | EP1438295A2 Azole derivatives and pharmaceutical compositions containing them |
| 07/21/2004 | EP1438293A2 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 07/21/2004 | EP1438291A1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 07/21/2004 | EP1438104A1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists |
| 07/21/2004 | EP1438053A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same |
| 07/21/2004 | EP1438048A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors |
| 07/21/2004 | EP1438046A2 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use |
| 07/21/2004 | EP1438035A2 Pharmaceutical compositions for the treatment of urinary disorders |
| 07/21/2004 | EP1438034A2 Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence |
| 07/21/2004 | EP1437944A1 Process for the fractionation of oilseed press cakes and meals |
| 07/21/2004 | EP1351942B1 Novel 2,3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient |
| 07/21/2004 | EP1320521B1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(en)oic acid as therapeutic agents |
| 07/21/2004 | EP1226137B1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 07/21/2004 | EP1144369B1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 07/21/2004 | EP0958282B1 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines |
| 07/21/2004 | CN1514834A Cyclohexylphenyl vasopression agonists |
| 07/21/2004 | CN1514732A Pharmaceutical formulation consisting of plant extract with calcium coating |
| 07/21/2004 | CN1514727A Favorable modulation of health-related quality of life and health-related quality-adjusted time-to progression of disease in patients with prostate cancer |
| 07/21/2004 | CN1513862A Preparation process of plantago fotal glycocide and its application in medicine |
| 07/21/2004 | CN1513844A New Carboxglic acid derivative, its preparation and application |
| 07/21/2004 | CN1513532A Chinese medicinal preparation for treating prostate disease and its preparation method |
| 07/21/2004 | CN1513526A Blood nourishing and toxin resolving medicine for treating AIDS |
| 07/21/2004 | CN1513498A Jin-Gui-Shen-Qi capsule beneficial to kidney and its prepn. method |
| 07/21/2004 | CN1513490A High effect pure traditional chinese medicine for treating kidney disease |
| 07/21/2004 | CN1513489A Enteroclysis liquid medicine for treating renal failure and its prepn. method |
| 07/21/2004 | CN1513488A Traditional chinese medicine powder for treating urinary system stone |
| 07/21/2004 | CN1513455A prepn. for stopping vomitus contg. compound pentoxifylline |
| 07/21/2004 | CN1513452A Use of CGMP phosphodiesterase inhibitor for treating sexual impotence |
| 07/21/2004 | CN1513447A Application of bamboo leaf total flavone in medicine for treating and preventing prostata disease and health-care-food |
| 07/21/2004 | CN1158290C Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
| 07/21/2004 | CN1158276C Phenyl-and pyridyl-tetrahydro-pyridines having TNF inhibiting activity |
| 07/21/2004 | CN1158259C Potassium channel openers |
| 07/21/2004 | CN1158081C Medicine composition containing active vitamin D compound and its use |
| 07/20/2004 | US6765022 Cyclohexylamine derivatives as subtype selective nmda receptor antagonists |
| 07/20/2004 | US6765012 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation |
| 07/20/2004 | US6765011 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 07/20/2004 | US6765009 1,4-Disubstituted benzo-fused compounds |
| 07/20/2004 | US6765004 Anticoagulants, antiischemic and hypotensive agents; cardiovascular disorders, congestive heart failure, liver cirrhosis, renal vasospasm, renal failure, cerebral edema and ischemia, strokes |
| 07/15/2004 | WO2004058754A1 Benzoazolypiperazine derivatives having mglur1- and mglur5-antagonistic activity |
| 07/15/2004 | WO2004058745A1 Optically active dihydropyridine derivative |
| 07/15/2004 | WO2004058256A1 Pharmaceutical liquid composition containing pyridone derivative |
| 07/15/2004 | WO2004039753A3 Phenyl compounds |
| 07/15/2004 | WO2004028440A3 Vr1 antagonists for the treatment of urological disorders |
| 07/15/2004 | WO2003100033A3 ANTI-αvβ6 ANTIBODIES |
| 07/15/2004 | WO2003087108A3 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses |
| 07/15/2004 | WO2003087040A3 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses |
| 07/15/2004 | WO2003086294A3 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 07/15/2004 | WO2003082197A3 Immunosuppressant compounds, methods and uses related thereto |
| 07/15/2004 | WO2003047506A3 Peptide agonists of prostate-specific antigen, and uses therefor |
| 07/15/2004 | WO2003044162A3 Genes encoding g-protein coupled receptors and methods of use therefor |
| 07/15/2004 | US20040138462 Aminoalcohol derivatives |
| 07/15/2004 | US20040138454 Drugs for treating pain formed by arylation |
| 07/15/2004 | US20040138416 Comprises membrane protein for use in diagnosis prevention and treatment of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune, inflammatory, metabolic and viral disorders |
| 07/15/2004 | US20040138287 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors |
| 07/15/2004 | US20040138286 Rho kinase inhibitors |
| 07/15/2004 | US20040138281 Parkinson's and Huntington's disease; psychoses, impotence, renal or heart failure, schizophrenia |
| 07/15/2004 | US20040138276 Metalloproteinase inhibitors |
| 07/15/2004 | US20040138264 Tetrahydropyridly-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same |
| 07/15/2004 | US20040138259 Pain management |
| 07/15/2004 | US20040138252 Pharmaceutical composition for therapy of interstitial cystitis |
| 07/15/2004 | US20040138251 Anticancer agents; osteoporosis; polycystic kidney disease; antiarthritic agents; organ transplant rejection |
| 07/15/2004 | US20040138241 Urogenital disorders; benign protatic hyperplasia |
| 07/15/2004 | US20040138225 Analgesics; gastrointestinal disorders; central nervous system injuries |
| 07/15/2004 | US20040138220 Central nervous system disorder; gastrointestinal disorders; asthma; skin disorders; inflammatory bowel disorders; analgesics |
| 07/15/2004 | US20040138143 Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
| 07/15/2004 | US20040138113 Administering heterodimeric polypeptides and optionally as mixtures with steroids, to mammals, as antiinflammatory agents; side effect reduction |
| 07/15/2004 | US20040137573 for drug screening treatments for pain, neuropathy, rheumatoid/osteo arthritis, stroke, inflammation, asthma, allergy, urogenital disorders, incontinence, hypertension, hypotension, perivasular disease; animal models; kits |
| 07/15/2004 | US20040137503 for analysing allelic variation a gene, and using polymorphism in treatment of diseases with gene-specific drugs |
| 07/15/2004 | US20040137074 Osteoprotegerin in milk |
| 07/15/2004 | US20040137006 an anti-allergic agent, comprising a molecule having at least a first segment competent for importation of the molecule into mast cells, and a second segment for having an anti-allergic effect within the mast cells |
| 07/15/2004 | US20040137001 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse |
| 07/15/2004 | US20040134387 obtained from plant by-products or waste suspended through wet-grinding and suspended by means of a microballs mill; includes silica fume, fly ashes, heavy ashes, slags or stone sludge, in form of pellets, sludge or blocks |
| 07/14/2004 | EP1437344A1 Benzene derivatives,process for preparing the same and use thereof |
| 07/14/2004 | EP1437132A1 Use of nitric ester derivatives in the manufacture of a medicament for the treatment of gastrointestinal tumors |
| 07/14/2004 | EP1437043A1 Model animal with overexpression of regucalcin |
| 07/14/2004 | EP1436624A1 A method of diagnosis and treatment and agents useful for same |
| 07/14/2004 | EP1436383A2 Secreted proteins |
| 07/14/2004 | EP1436381A1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 07/14/2004 | EP1436327A1 Ee3-protein family and corresponding dna sequences |
| 07/14/2004 | EP1436323A1 Crystal structure of baff, and use thereof in drug design |
| 07/14/2004 | EP1436322A2 Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 07/14/2004 | EP1436318A2 Ncam binding compounds |
| 07/14/2004 | EP1436298A1 Himbacine analogues as thrombin receptor antagonists |
| 07/14/2004 | EP1436290A1 Alkyne-aryl-naphthyridin-4(1h)-0ne derivatives as type iv phosphodiesterase inhibitor |
| 07/14/2004 | EP1436281A1 Piperidine- and piperazineacetamides as 17beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 07/14/2004 | EP1436272A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |